My watch list
my.chemeurope.com  
Login  

Laquinimod



Laquinimod
IUPAC name 5-chloro-N-ethyl-4-hydroxy-1-methyl-2-oxo-
N-phenyl-1,2-dihydroquinoline-3-carboxamide
Identifiers
CAS number 248282-07-7
PubChem 216469
SMILES CCN(c1ccccc1)C(=O)C\3=C(/O)c2c(Cl)cccc2N(C)C/3=O
Properties
Molecular formula C19H17ClN2O3
Molar mass 356.803 g/mol
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

Laquinimod is an immunomodulator developed by Active Biotech and produced by Teva Pharmaceutical Industries. It is currently under development in phase III trials for treatment of multiple sclerosis as an oral therapy, like fingolimod.

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Laquinimod". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE